Comparison of two reverse transcription-polymerase chain reaction methods for detection of AML1/ETO rearrangement in the M2 subtype of acute myeloid leukaemia

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 3, 1998, Pages 137-142

  Barragán, Eva ^a   Bonanad, Santiago ^a   López, José Antonio ^a   Bolufer, Pascual ^a   Sanz, Miguel Angel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute myeloid leukaemia; AML1 ETO rearrangement; M2 subtype of acute myeloid leukaemia; Reverse transcription polymerase chain reaction

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CASE REPORT; CELL LINE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

BASE SEQUENCE; BLOTTING, SOUTHERN; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 0031899749     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.026     Document Type: Article

References (22)

1. Berger R, Flandrin G, Berheim A, Le Coniat M, Vecchione D, Pacot A, et al. Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukaemias. Cancer Genet Cytogenet 1987; 29:9-21.
2. Fenaux P, Preudhome C, Lai JL, Morel P, Beuscart R, Bauters F. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases. Br J Haematol 1989; 73:61-7.
3. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ. 8;21 Translocation in acute granulocytic leukaemia: cytological cytochemical and clinical features. Br J Haematol 1984; 56:199-213.
4. Erickson P, Gae J, Chang KS, Look T, Whisenant E, Raimondi S, et al. Identification of breakpoints in t(8;21) acute myelogenous leukaemia and isolation of a fusion transcript AML1/ETO with similarity to Drosophila segmentation gene, runt. Blood 1992; 80:1825-30.
5. Erickson P, Robinson M, Owens G, Drabkin HA. The ETO portion of acute myeloid leukaemia t(8;21) fusion transcript encodes a highly evolutionary conserved putative transcription factor. Cancer Res 1994; 54:1782-6.
6. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995; 86:1-14.
7. Nucifora G, Birn DJ, Erickson P, Gao J, LeBeau MM, Drabkin HA, et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81:883-8.
8. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, et al. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22) translocation. Blood 1993; 81:2860-5.
9. Satake N, Maseki N, Kozu T, Sakashita A, Kobayashi H, Sakurai M, et al. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. Br J Haematol 1995; 91:892-8.
10. Hiroya A, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77:2031-6.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
12. Kozu T, Myoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, et al. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993; 82:1270-6.
13. Tighe J, Calabi F. Alternative, out-of-frame runt/MTG8 transcripts are encoded by derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M2. Blood 1994; 84:2115-21.
14. Van de Locht LTF, Smetsers TFCM, Wittebol S, Raymakers AP, Mensink EJBM. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21 ) positive acute myeloid leukaemia. Leukemia 1994; 8:1780-4.
15. Kusec R, Laczika K, Knöbl P, Friedl J, Greinix H, Kahls P, et al. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8:735-9.
16. Nucifora G, Larson RA, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82:712-5.
17. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, et al. Persistence of the AML1/ETO fusion transcript in patients treated with allogenic bone marrow transplantation for t(8;21) leukemia. Blood 1996; 88:2183-91.
18. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 1993; 84:67-74.
19. Mayurama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T, et al. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 1994; 8:40-5.
20. Nucifora G, Dickstein JI, Toberson V, Roulston D, Rowley JD, Vardiman JW. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 1994; 8:1533-8.
21. Langabeer SE, Walker H, Gale RE, Wheatley K, Burnett AK, Goldstone AH. Frequency of CBFb/MYH11 fusion transcripts in patients entered into U.K. MCR AML trials. Br J Haematol 1997; 96:736-9.
22. Saunders MJ, Tobal K, Keeney S, Liu-Yin JA. Expression of diverse AML1/METG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase. Leukemia 1966 10:1139-42.